Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling
Abroad (travel likely)RecruitingPHASE2
Conditions
Acute Myeloid Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Department of Hematology, Rigshospitalet, Copenhagen, Denmark
Contact: Study coordinator (Mette H Thrane, Master of Public Health) · mette.hoejmose.thrane.01@regionh.dk · +4535450944Contact: Study coordinator (Julie Palmer Rohold, MSc) · julie.palmer.rohold@regionh.dk · +4535455111Contact: Principal Investigator (Kim Theilgaard-Mönch)Contact: Principal Investigator (Anne Louise T Sørensen)